Clinical characteristics, treatment patterns, disease burden, and persistence/adherence in patients with asthma initiating inhaled triple therapy: real-world evidence from Japan-Reference-Cited by-同舟云学术

Clinical characteristics, treatment patterns, disease burden, and persistence/adherence in patients with asthma initiating inhaled triple therapy: real-world evidence from Japan

Published:2020-05-14 Issue:6 Volume:36 Page:1049-1057
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Suzuki Takeo¹^ORCID,Fairburn-Beech Jolyon²^ORCID,Sato Keiko¹^ORCID,Kaise Toshihiko¹^ORCID

Affiliation:

1. Value Evidence Outcomes Department, Japan Development Division, GlaxoSmithKline K.K, Tokyo, Japan

2. Value Evidence and Outcomes Department, GlaxoSmithKline, London, UK

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2020.1763937

Reference34 articles.

1. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015

2. Nationwide Cross-Sectional Population-Based Study on the Prevalences of Asthma and Asthma Symptoms among Japanese Adults

3. Japanese guidelines for adult asthma 2017

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating the timing of triple therapy initiation for the treatment of asthma in Japan: prompt versus delayed;Journal of Asthma;2024-08-30

2. Asthma prescribing trends, inhaler adherence and outcomes: a Real-World Data analysis of a multi-ethnic Asian Asthma population;2024-07-11

3. Real-world characteristics of patients with asthma initiating fluticasone furoate/umeclidinium/vilanterol single-inhaler triple therapy in Japan;Respiratory Investigation;2024-07

4. Characteristics, treatment patterns and burden of illness in US patients with asthma newly initiating multiple-inhaler triple therapy;BMJ Open Respiratory Research;2024-03

5. Real-World Users of Triple Therapy for Asthma in the US;The American Journal of Managed Care;2024-02-01